-
1 Comment
Huadong Medicine Co., Ltd is currently in a long term uptrend where the price is trading 18.9% above its 200 day moving average.
From a valuation standpoint, the stock is 79.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.0.
Huadong Medicine Co., Ltd's total revenue sank by 5.7% to $9B since the same quarter in the previous year.
Its net income has increased by 7.0% to $660M since the same quarter in the previous year.
Finally, its free cash flow grew by 192.1% to $304M since the same quarter in the previous year.
Based on the above factors, Huadong Medicine Co., Ltd gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE0000011S1 |
| Exchange | SHE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 2.5% |
|---|---|
| Beta | 0.6 |
| Market Cap | 69B |
| PE Ratio | 18.53 |
| Target Price | 45.49 |
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, and medical apparatus and equipment. It also manufactures and sells antibiotics, Chinese patent medicines, synthetic drugs, and genetic engineering drugs; and engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides business, leasing, and warehousing services. The company has a strategic cooperation agreement with SynerK PharmaTech (Suzhou) Co., Ltd. to develop the small nucleic acid (siRNA) drug SNK-2726, an angiotensinogen (AGT) for the treatment of hypertension. Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000963.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
